Across TCGA pan-cancer cohorts, VN1R17P RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of VN1R17P’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where VN1R17P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types VN1R17P is over-expressed in tumor.
KIRP are the cancer types where VN1R17P tumor–normal differential expression is most reproducible.